These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27270764)

  • 1. Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines.
    Tanaka K; Miyazawa M; Mikami M; Aoki D; Kiguchi K; Iwamori M
    Glycoconj J; 2016 Oct; 33(5):745-54. PubMed ID: 27270764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of gangliosides with GM2-determinant in cervical carcinoma-derived cells after subcutaneous transplantation into nude mice.
    Tanaka K; Murakami I; Mikami M; Aoki D; Iwamori M
    Hum Cell; 2023 May; 36(3):1199-1203. PubMed ID: 36932279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats.
    Halstead SK; Jackson M; Bianchi E; Rupp S; Granger N; Menchetti M; Galli G; Freeman P; Kaczmarska A; Bhatti SFM; Brocal J; José-López R; Tipold A; Gutierrez Quintana R; Ives EJ; Liatis T; Nessler J; Rusbridge C; Willison HJ; Rupp A
    J Peripher Nerv Syst; 2023 Mar; 28(1):32-40. PubMed ID: 36573790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
    Trinchera M; Ghidoni R
    J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of UDP-GalNAc:NeuAc alpha 2,3Gal-R beta 1,4(GalNAc to Gal)N-acetylgalactosaminyltransferase in human stomach. Enzymatic synthesis of a fundic gland-specific ganglioside and GM2.
    Dohi T; Hanai N; Yamaguchi K; Oshima M
    J Biol Chem; 1991 Dec; 266(35):24038-43. PubMed ID: 1748676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F.
    Hidari JK; Ichikawa S; Furukawa K; Yamasaki M; Hirabayashi Y
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):957-65. PubMed ID: 7980468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression.
    Ruan S; Raj BK; Furukawa K; Lloyd KO
    Arch Biochem Biophys; 1995 Oct; 323(1):11-8. PubMed ID: 7487055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
    Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
    Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
    Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
    Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
    J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase.
    Rosales Fritz VM; Daniotti JL; Maccioni HJ
    Biochim Biophys Acta; 1997 Nov; 1354(2):153-8. PubMed ID: 9396632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside expression in human pancreatic islets.
    Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
    Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder.
    Nakao T; Kon K; Ando S; Miyatake T; Yuki N; Li YT; Furuya S; Hirabayashi Y
    J Biol Chem; 1993 Oct; 268(28):21028-34. PubMed ID: 7691804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
    Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
    Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
    Fujikawa K; Nakashima S; Konishi M; Fuse T; Komura N; Ando T; Ando H; Yuki N; Ishida H; Kiso M
    Chemistry; 2011 May; 17(20):5641-51. PubMed ID: 21469228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.